Philipp Richard, Manager, Account & Business Development, Ypsomed, discusses the evolution of self-injection devices and the shift to platform-based development and the manufacturing challenges this have developed over the course of this evolution. By enabling flexibility and building a geographically distributed supply chain the company aims to address these challenges.
To read this white paper, click this text.
To learn more about Drug Delivery and the PODD Conference, please visit drug-delivery.org.
In this article
Philipp Richard, MBA
Account & Business Development Manager
Ypsomed
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.